期刊
CELL CYCLE
卷 16, 期 10, 页码 1008-1014出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/15384101.2017.1315489
关键词
BxPC-3; cancer cells; color-coded intravital imaging; GFP; orthotopic mouse model; pancreatic cancer; RFP; stromal cells; TGF- inhibitor
类别
Pancreatic cancer is a recalcitrant malignancy, partly due to desmoplastic stroma which stimulates tumor growth, invasion, and metastasis, and inhibits chemotherapeutic drug delivery. Transforming growth factor- (TGF-) has an important role in the formation of stromal desmoplasia. The present study describes the ability of color-coded intravital imaging to demonstrate the efficacy of a TGF- inhibitor to target stroma in an orthotopic mouse model of pancreatic cancer. The BxPC-3 human pancreatic adenocarcinoma cell line expressing green fluorescent protein (GFP), which also has a high TGF- expression level, was used in an orthotopic model in transgenic nude mice ubiquitously expressing red fluorescent protein (RFP). Fourteen mice were randomized into a control group (n = 7, vehicle, i.p., weekly, for 3weeks) and a treated group (n = 7, SB431542 [TGF- receptor type I inhibitor] 0.3mg, i.p., weekly, for 3weeks). Stromal cells expressing RFP and cancer cells expressing GFP were observed weekly for 3weeks by real-time color-coded intravital imaging. The RFP fluorescence area from the stromal cells, relative to the GFP fluorescence area of the cancer cells, was significantly decreased in the TGF--inhibitor-treatment group compared to the control group. The present study demonstrated color-coded imaging in an orthotopic pancreatic-cancer cell-line mouse model can readily detect the selective anti-stromal-cell targeting of a TGF- inhibitor.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据